Nkarta Inc
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflam… Read more
Nkarta Inc (NKTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.055x
Based on the latest financial reports, Nkarta Inc (NKTX) has a cash flow conversion efficiency ratio of -0.055x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.69 Million) by net assets ($337.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nkarta Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Nkarta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nkarta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nkarta Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu United Water Technology Co. Ltd. Cl A
SHG:603291
|
N/A |
|
Sligro Food Group N.V.
PINK:SIGRF
|
0.059x |
|
Adira Dinamika Multi Finance
JK:ADMF
|
0.067x |
|
Shanghai Longyun Advg & Media
SHG:603729
|
0.031x |
|
Belpointe REIT Inc
OTCQX:BELP
|
-0.038x |
|
Zhejiang Jindao Technology Co. Ltd.
SHE:301279
|
N/A |
|
Axtel S.A.B. de C.V
OTCGREY:AXTLF
|
0.475x |
|
Geospace Technologies Corporation
NASDAQ:GEOS
|
-0.130x |
Annual Cash Flow Conversion Efficiency for Nkarta Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Nkarta Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $407.98 Million | $-99.70 Million | -0.244x | +22.49% |
| 2023-12-31 | $273.29 Million | $-86.16 Million | -0.315x | -105.87% |
| 2022-12-31 | $372.21 Million | $-57.00 Million | -0.153x | +43.42% |
| 2021-12-31 | $250.97 Million | $-67.93 Million | -0.271x | -99.84% |
| 2020-12-31 | $321.22 Million | $-43.51 Million | -0.135x | -118.79% |
| 2019-12-31 | $-25.48 Million | $-18.37 Million | 0.721x | -24.97% |
| 2018-12-31 | $-5.40 Million | $-5.18 Million | 0.961x | -- |